to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Each year, 552,000 employer firms open in the U.S. and a fairly stable percentage grow rapidly to become companies that ‘matter.’ According to a new paper from Kauffman Foundation senior fellow Paul Kedrosky, anywhere from 125 to 250 U.S. companies per year reach $100 million in revenues—the first of three criteria that he uses to determine if they matter. In addition to being scalable, the firms must be able to generate jobs quickly and broadly and they must be disproportionate creators of wealth (through profits and salaries as well as through equity). So where do most of these firms emerge?
While all eyes in the Senate are on the ongoing immigration debate, the House has a handful of committee hearings of interest. The “changing landscape of patent law” brought on by the American Invents Act and its “effects on small firms” are the focus of a Small Business Committee hearing. Topics covered in other hearings include: small business and pass-through entity tax reform; data centers and the cloud; copyright principles; and Keystone XL and small business job growth.
Global interest in the emerging entrepreneurial economies of Latin America has been on the rise. It is where Endeavor began—launching in Chile and Argentina in 1997—and more recently, the region’s vibrant cultures have led the likes of Geeks on a Plane and the Global Entrepreneurship Congress to take a closer look. This spring we report back from a few economies in the region.
‘Entrepreneur visas’ aren’t only being discussed in Washington, DC. Recently, French President Francois Hollande announced a series of measures aimed at jump-starting entrepreneurial growth that included capital gains tax reforms, support services for SMEs and entrepreneur visas for those looking to launch and grow startups in the country.
Is the U.S. losing the global race for the best and brightest entrepreneurial talent? It depends who you ask, but the question is the main focal point of the latest program from America Abroad Media entitled ‘Immigration and the Global Talent Search’—part of a four-part series on American entrepreneurship in a global economy.
Find out what this weeks eMed's 6 to follow entrepreneurs had to say.
Because significant funding is needed to develop new, innovative life science and digital health products and tools, fewer ideas are making the leap from research institutions to product development teams. This clash between the short-term, earnings-driven needs of the medical marketplace and the risky, lengthy, and capital-intensive process of bringing medical ideas to fruition is a major challenge facing modern medicine.
"Med tech is alive and well, despite what we hear out there," Kevin Wasserstein, founder and principal at MentorCatalyst, told the attendees of today’s MedTech Investing Conference.
Dinu Sen, CEO of Amplyx Pharmaceuticals, offers tips on finding need in the sector, hiring, and determining whether working with an accelerator is right for your company.
Medical technology innovators and investors from across the country will gather Wednesday in Minneapolis for the 12th annual MedTech Investing Conference. With panels on alternative funding models, maximizing ROI, and the FDA on the agenda, we asked conference co-chair Dennis Wahr, CEO of Holaira, what insights life science and digital health entrepreneurs can expect to take away from the event.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
